Cohort StudyTreatment: Trigger Point InjectionClinical TrialsClinical RelevanceDOI
4 min read
Jump to:

Patient-friendly summary

If you read nothing else

This study looked at how a quick pain reliever injection, called trigger point injection, can help people with a type of pain from cancer. It found that if patients felt better right after the injection, their pain was likely to stay better for a week.

Bottom line

This study suggests that trigger point injection with local anesthetic can help manage pain in people with incurable cancer, and it might work better when patients expect it to.

Preliminary evidence

Published

2021
5 years ago
Recent

Evidence hierarchy

Meta-analysis
Systematic Review
RCT
Cohort ◀ this study
Case-Control
Case Report
Expert Opinion

Study participants

n=20568.3 on average48.7% women

Patients with incurable cancer experiencing myofascial pain syndrome

Words decoded

myofascial pain syndrome (MPS)
— A type of pain caused by sensitive spots in muscles called trigger points.
trigger point injection (TPI)
— A procedure where a doctor injects medicine into a trigger point to help reduce pain.
numerical rating scale (NRS)
— A scale used to measure pain intensity, where 0 is no pain and 10 is the worst possible pain.
Full research — for clinicians and curious readers

Study Summary

Background

This study examined whether the immediate pain relief experienced after trigger point injections affects how well patients respond to treatment over the following week. Previous research showed that patient expectations can influence treatment outcomes, but it was unclear whether immediate pain relief creates positive expectations that lead to better long-term results. The researchers focused on cancer patients with myofascial pain syndrome, a condition where muscle trigger points cause significant pain and are common in advanced cancer.

What They Did

The researchers followed 205 cancer patients who received trigger point injections with local anesthetic (1ml of 1% lidocaine) for myofascial pain. They measured pain levels and expectations before treatment, immediately after, and at 1, 3, and 7 days post-injection. Patients were divided into two groups: those who experienced immediate pain relief (33% or greater reduction within 5-20 minutes) and those who did not. The team used sophisticated statistical analysis called path analysis to understand how immediate effects, expectations, and pain outcomes were connected.

What They Found

Of the 205 patients, 58.1% experienced immediate pain relief after injection. This immediate effect group had dramatically better outcomes at 7 days: 88.2% showed meaningful pain reduction compared to only 39.5% in the non-immediate effect group. The immediate effect group also developed higher expectations for pain relief that lasted throughout the week. The path analysis revealed that immediate pain relief influenced long-term outcomes both directly and indirectly through increased patient expectations.

The indirect effect through expectations was actually stronger than the direct effect, suggesting that the psychological boost from immediate relief is crucial for sustained improvement.

What This Means

This research provides important evidence that the immediate response to trigger point injections predicts how well patients will do over the following week. For clinicians, this suggests that achieving immediate pain relief during the procedure may be critical not just for immediate comfort, but for setting up positive expectations that support ongoing recovery. This finding could help doctors better predict which patients will benefit most from trigger point injections and potentially guide decisions about treatment approaches. For patients, experiencing immediate relief after injection is a positive sign that the treatment will likely continue helping over the next week.

65/100
Evidence StrengthModerate
Study Quality
Sample Size
Replication
58.1%
Had Immediate Pain Relief
88.2%
Pain Reduction at 7 Days (Immediate Group)
39.5%
Pain Reduction at 7 Days (Non-Immediate Group)
p<0.001
Statistical Significance
Enrolled

205

Randomized
n=119

Immediate Effect

Experienced ≥33% pain reduction within 5-20 minutes

n=86

Non-Immediate Effect

Did not experience immediate pain relief

Results Comparison

Pain Reduction Rate at 7 Days

%
Immediate Effect88.2 %
Non-Immediate Effect39.5 %

Key Findings

Immediate pain relief strongly predicted 7-day outcomesHigh

88.2% of immediate effect group vs 39.5% of non-immediate group had pain reduction at 7 days

Expectations mediated the relationship between immediate and sustained effectsHigh

Path analysis showed indirect effect through expectations (β=0.285) was stronger than direct effect (β=0.194)

Over half of cancer patients experienced immediate reliefMedium

58.1% (95% CI: 51.2-64.9) had immediate pain reduction ≥33% after trigger point injection

Increased expectations were maintained throughout follow-upMedium

Immediate effect group maintained significantly higher pain relief expectations at all time points

No adverse events occurredMedium

All 205 trigger point injections were completed without complications during evaluation period

Study Methodology
Study Design
Prospective observational cohort study using path analysis
Sample Size
205
Duration
7-day follow-up period
Population
Cancer patients with incurable disease and myofascial pain syndrome
Outcome Measures
Numerical Rating Scale for pain · NRS for pain relief expectations · Demographics · Cancer characteristics

Strengths

  • Large sample size of 205 cancer patients
  • Sophisticated path analysis to understand causal relationships
  • Clear operational definitions for immediate effect and pain reduction
  • Comprehensive assessment of expectations and pain outcomes
  • No adverse events reported

Limitations

  • Observational study design limits causal inferences
  • Single-center study may limit generalizability
  • Short 7-day follow-up period for cancer patients
  • Expectations questionnaire validity not established
  • Limited to patients with incurable cancer

Key Takeaways for Patients

What This Means for You

  1. 01If you feel immediate pain relief after a trigger point injection, you're likely to continue feeling better over the next week
  2. 02The immediate response to treatment can help boost your confidence and expectations, which may enhance the treatment's effectiveness
  3. 03Trigger point injections appear safe in cancer patients with no serious side effects reported in this study
  4. 04About 6 out of 10 cancer patients experience immediate pain relief from trigger point injections
  5. 05Your response in the first 20 minutes after injection may help your doctor predict how well the treatment will work for you

Read the Full Paper

Access the complete peer-reviewed study from Frontiers in Psychiatry

View Full Study

Related Research

●●●●● LandmarkMeta-analysis

Trigger Point Injections Versus Medical Management for Acute Myofascial Pain: A Systematic Review and Meta-Analysis

Haroutiun Hamzoian & Vahe Zograbyan·Cureus·2023

A meta-analysis of four RCTs found that trigger point injections significantly reduced acute myofascial pain compared with medical management alone (SMD -2.09; 95% CI -3.34 to -0.85; P = 0.001), though the authors flag notable heterogeneity and bias concerns.

Trigger Point InjectionRead →
●●●●● LandmarkMeta-analysis

Local Anesthetic Injections for the Short-Term Treatment of Head and Neck Myofascial Pain Syndrome: A Systematic Review with Meta-Analysis

Nouged et al.·Journal of Oral & Facial Pain and Headache·2019

Systematic review of 884 patients found local anesthetic trigger point injections showed only modest benefits over dry needling for head and neck myofascial pain. Benefits disappeared when only high-quality studies were analyzed, suggesting bias may explain apparent advantages.

Trigger Point InjectionRead →
●●●●● LandmarkNarrative Review

Treatment of Myofascial Pain Syndrome

Hong, Chang-Zern·Current Pain and Headache Reports·2006

Comprehensive review establishing that successful myofascial pain treatment requires addressing underlying causes before trigger point therapy. Multiple treatment modalities are effective, but lasting relief depends on treating root pathology and patient education.

Trigger Point InjectionRead →
●●●●○ StrongCase Report/Series

The paravertebral fascial plane block: A novel, ultrasound-guided technique for paraspinal neck and back pain

Aulia et al.·American Journal of Emergency Medicine·2026

A novel ultrasound-guided fascial injection technique provided rapid, sustained pain relief for 11 emergency department patients with refractory paraspinal myofascial pain. Pain scores dropped from 9/10 to 1/10 at 48-hour follow-up with no complications.

Trigger Point InjectionRead →